Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
4.750
+0.099 (2.13%)
Feb 6, 2026, 4:00 PM EST - Market closed

Rallybio Revenue

Rallybio had revenue of $212.00K in the quarter ending September 30, 2025, a decrease of -29.10%. This brings the company's revenue in the last twelve months to $674.00K, up 12.71% year-over-year. In the year 2024, Rallybio had annual revenue of $636.00K.

Revenue (ttm)
$674.00K
Revenue Growth
+12.71%
P/S Ratio
39.50
Revenue / Employee
$44,933
Employees
15
Market Cap
25.08M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024636.00K--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Palatin Technologies8.85M
Evaxion7.65M
IGC Pharma1.11M
Serina Therapeutics116.00K
Daré Bioscience-57.13K
Revenue Rankings